{"id":"NCT01009580","sponsor":"Novo Nordisk A/S","briefTitle":"Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes","officialTitle":"A 26-week, Randomised, Open-labelled, Two-arm, Parallel-group, Treat-to-target Trial Comparing Efficacy and Safety of Soluble Insulin Analogue Combination (SIAC) Twice Daily (BID) With Biphasic Insulin Aspart (BIAsp) 30 BID, With or Without Metformin, With or Without DPP-4 Inhibitor, With or Without Pioglitazone in Subjects With Type 2 Diabetes in Inadequate Glycaemic Control on Once or Twice Daily Premixed or Self-mixed Insulin Regimen With or Without OADs (BOOST™: Intensify Premix 1)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-11-05","primaryCompletion":"2010-08-23","completion":"2010-08-23","firstPosted":"2009-11-06","resultsPosted":"2015-11-20","lastUpdate":"2018-12-19"},"enrollment":447,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"insulin degludec/insulin aspart","otherNames":[]},{"type":"DRUG","name":"biphasic insulin aspart 30","otherNames":[]}],"arms":[{"label":"IDegAsp BID","type":"EXPERIMENTAL"},{"label":"BIAsp 30 BID","type":"EXPERIMENTAL"}],"summary":"This trial is conducted in Asia, Europe and Oceania. The aim of this clinical trial is to compare NN5401 (insulin degludec/insulin aspart) with biphasic insulin aspart 30 in subjects with type 2 diabetes.","primaryOutcome":{"measure":"Change in Glycosylated Haemoglobin (HbA1c)","timeFrame":"Week 0, Week 26","effectByArm":[{"arm":"IDegAsp BID","deltaMin":-1.28,"sd":0.94},{"arm":"BIAsp 30 BID","deltaMin":-1.3,"sd":0.97}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":6},"locations":{"siteCount":53,"countries":["Australia","Denmark","Finland","India","Malaysia","Poland","Sweden","Taiwan","Thailand","Turkey (Türkiye)"]},"refs":{"pmids":["27553066","24812432","26612062","29451706","30474818","35044568"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":19,"n":224},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Headache","Pyrexia"]}}